Search research articles
Contact Us
Filters
Showing results (41-50 of 200) with videos related to
Page
of 20
Sort By:
Progress in Cardiovascular Diseases
|
August 24, 2010
Reversibility of left ventricular dysfunction resulting from chemotherapy: can this be expected?
Quinn S Wells, Daniel J Lenihan
Heart Failure Clinics
|
July 14, 2011
Heart disease in cancer patients: a burgeoning field where optimizing patient care is requiring interdisciplinary collaborations
Daniel J Lenihan, Douglas B Sawyer
Journal of Cardiac Failure
|
June 1, 2014
Loop diuretic resistance in heart failure: resistance etiology-based strategies to restoring diuretic efficacy
Zachary L Cox, Daniel J Lenihan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2012
Late cardiac effects of cancer treatment
Daniel J Lenihan, Daniela M Cardinale
Herz
|
June 3, 2011
Neuregulin in heart failure : reverse translation from cancer cardiotoxicity to new heart failure therapy
C A Geisberg, D J Lenihan
The American Journal of Medicine
|
January 27, 2022
Introduction to 'Proceedings from Amyloidosis, A Hidden Disease with a Bright Future: A Multi-Disciplinary Approach to Diagnosis and Management of Amyloidosis'
Kathleen W Zhang, Daniel J Lenihan
Echocardiography (Mount Kisco, N.Y.)
|
February 22, 2001
Sarcoidosis-induced right ventricular hypertrophy and pulmonary hypertension: echocardiographic imaging
F J Otero, D J Lenihan
The Oncologist
|
March 20, 2014
In reply
Daniel J Lenihan, Peter R Kowey
Heart Failure Clinics
|
June 19, 2022
Clinical Practice Guidelines in Cardio-Oncology
Darryl P Leong, Daniel J Lenihan
Clinics in Geriatric Medicine
|
August 5, 2000
Nonpharmacologic treatment of heart failure in the elderly
D J Lenihan, B F Uretsky
Page
of 20
Search research articles
Search
Showing results (41-50 of 200) with videos related to
Sort By:
Page
of 20
Progress in Cardiovascular Diseases
|
August 24, 2010
Reversibility of left ventricular dysfunction resulting from chemotherapy: can this be expected?
Quinn S Wells, Daniel J Lenihan
Heart Failure Clinics
|
July 14, 2011
Heart disease in cancer patients: a burgeoning field where optimizing patient care is requiring interdisciplinary collaborations
Daniel J Lenihan, Douglas B Sawyer
Journal of Cardiac Failure
|
June 1, 2014
Loop diuretic resistance in heart failure: resistance etiology-based strategies to restoring diuretic efficacy
Zachary L Cox, Daniel J Lenihan
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2012
Late cardiac effects of cancer treatment
Daniel J Lenihan, Daniela M Cardinale
Herz
|
June 3, 2011
Neuregulin in heart failure : reverse translation from cancer cardiotoxicity to new heart failure therapy
C A Geisberg, D J Lenihan
The American Journal of Medicine
|
January 27, 2022
Introduction to 'Proceedings from Amyloidosis, A Hidden Disease with a Bright Future: A Multi-Disciplinary Approach to Diagnosis and Management of Amyloidosis'
Kathleen W Zhang, Daniel J Lenihan
Echocardiography (Mount Kisco, N.Y.)
|
February 22, 2001
Sarcoidosis-induced right ventricular hypertrophy and pulmonary hypertension: echocardiographic imaging
F J Otero, D J Lenihan
The Oncologist
|
March 20, 2014
In reply
Daniel J Lenihan, Peter R Kowey
Heart Failure Clinics
|
June 19, 2022
Clinical Practice Guidelines in Cardio-Oncology
Darryl P Leong, Daniel J Lenihan
Clinics in Geriatric Medicine
|
August 5, 2000
Nonpharmacologic treatment of heart failure in the elderly
D J Lenihan, B F Uretsky
Page
of 20